Navigation Links
Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
Date:10/8/2007

gh fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with INVEGA and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.

INVEGA should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.

INVEGA and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use. Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.

High blood sugar and diabetes have been reported with INVEGA and similar medications. If the person being treated has diabetes or risk factors such as being overweight or a family history of diabetes, blood sugar testing should be performed at the beginning and throughout treatment with INVEGA. Complications of diabetes can be serious and even life threatening. If signs of high blood sugar or diabetes develop, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry, contact your doctor.

People with narrowing or blockage of the
'/>"/>

SOURCE Janssen
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NimbleGen microarrays speed genetic findings
2. Jellyfish launches comparative shopping website
3. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
4. Epitope-Tagging Vectors for Functional Analysis in Yeast
5. Map and Link Human Genetic Disorders with SSLP Analysis
6. CastAway Precast Gels for Rapid Automated DNA Sequence Analysis
7. Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf cMaster RTplusPCR System
8. High-throughput gene expression analysis to screen for anti-asthma drugs
9. Fully automated DNA purification and efficient multiplex PCR for analysis of microsatellite loci
10. Structural Analysis of Glycosylated Peptides in Complex Mixtures with Ion Trap MSn
11. Use of Transcriptor Reverse Transcriptase in Microarray Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... --  PureTech , a science and technology R&D company ... technologies in the healthcare sector, announced today the appointment ... of the Board of Directors of Sanofi, to its ... a pleasure to know Chris for many years and ... together more closely now," said Dr. Robert Langer ...
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Already well ... gauging line by expanding its Length Gauge offerings with ... gauges. , Specifically, HEIDENHAIN’s pencil probe-style SPECTO ... force specification. Two new 1Vpp, 12mm stroke length ... force applications. One is a variant with a weak ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2
... 4, 2012 Luminex Corporation (NASDAQ: LMNX) today announced ... Morgan Healthcare Conference to be held January 9 -12, ... http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) The investor presentation by Patrick ... at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) on ...
... Jan. 4, 2012  Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today ... will be presenting at JP Morgan,s 30th Annual Healthcare ... Mr. Bentsur,s presentation is scheduled to take place on ... ET).  A live audio webcast of Mr. ...
... InterMune, Inc. (NASDAQ: ITMN) today announced that it ... sales of Esbriet® (pirfenidone) in Germany, as well as ... the open of the U.S. markets on Thursday, January ... be hosted by InterMune at 8:30 a.m. Eastern time ...
Cached Biology Technology:Luminex Corporation to Present at JP Morgan Healthcare Conference 2Keryx Biopharmaceuticals to Present at JP Morgan's 30th Annual Healthcare Conference 2InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5 2
(Date:2/18/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that its ... investors to participate via webcast. , Cowen and Company ... March 3, 2015 at 11.20 a.m. Eastern Time , ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... for these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... filed provisional patent 62/113114 for DISTRIBUTED METHOD ... The patent further establishes NXT-ID,s position in ... intellectual property portfolio the ability for multiple devices to ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... experts on biodiversity will gather from the 21th to the ... the transfer of biodiversity knowledge from the scientific community into ... in a project funded by the European Commission: " BiodiversityKnowledge ... practitioners to help all actors in the field of biodiversity ...
... Exercise clears the mind. It gets the blood pumping ... is familiar territory, but Dartmouth,s David Bucci thinks there ... several years there have been data suggesting that neurobiological ... work here," says Bucci, an associate professor in the ...
... Scientists at Queen Mary, University of London have ... underlying causes of psychiatric disorders. The study, published ... found zebrafish can modify their behaviour in response to ... School of Biological and Chemical Sciences who led the ...
Cached Biology News:A network of knowledge on biodiversity and ecosystem services in Europe 2Dartmouth researchers are learning how exercise affects the brain 2Dartmouth researchers are learning how exercise affects the brain 3Zebrafish could hold the key to understanding psychiatric disorders 2
... polystyrene with frosted labeling surfaces, volume ... counting. 100% integrity tested. Linkage: This ... number, created to easily match Cornings ... yet, please order under the old ...
Automated Cell Culture Flask...
... system, 100-240 V, uses multiplex suspension array ... of up to 100 proteins and peptides ... array is composed of up to 100 ... be conjugated with a unique reactant specific ...
...
Biology Products: